Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190016/S010

Tula System

Tusker Medical, Inc. · Decision date Oct 24, 2025

FDA DECISIONP190016/S010

What did the FDA decide?

FDA records P190016/S010 as a supplement to PMA P190016, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 24, 2025.

FDA approval order statement

approval for removal of lot release testing for Tula Tube Delivery System (TDS)
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ear, Nose, Throat
Decision date
Oct 24, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P190016/S010
Regulatory pathway
PMA supplement
Product code
QJA
Decision code
OK30
Decision date
Oct 24, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Tympanostomy tube delivery product with drug.

Product code
QJA
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P190016/S010 received

    Application receipt date recorded by FDA.

  2. P190016/S010 · FDA decision

    30-Day Notice

  3. P190016/S011 · Related supplement

    Tula Tube Delivery System (TDS)

Timeline entries are records held by MedtechLedger for P190016. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190016

Product / regulatory recordCompanyPathwayDecision dateSource
Tusker Medical, Inc.PMA supplementJan 21, 2026FDA
Tula SystemP190016/S012
Tusker Medical, Inc.PMA supplementJul 31, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Tusker Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
155 Jefferson Dr., Suite 200, Menlo Park, CA, 94025

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records